CA
CKPT

Cetera Advisors’s Checkpoint Therapeutics CKPT Stock Holding History

Cetera Advisors’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$25.4K Buy
+12,366
New +$24.7K ﹤0.01% 2390

Other funds holding CKPT

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
LWAM
Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 35.19% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Cetera Advisors's CKPT Position: Q1 2024 in Review

Cetera Advisors opened a new position in Checkpoint Therapeutics (CKPT) in Q1 2024: 12,366 shares worth $25.4K. The stake represents ﹤0.01% of the portfolio and ranks #2390 among its holdings.

40 funds tracked by Wall St. Rank hold CKPT as of Q1 2024.

  • Cetera Advisors held 12,366 shares of Checkpoint Therapeutics worth $25.4K as of Q1 2024.
  • Checkpoint Therapeutics was a new Cetera Advisors position in Q1 2024.
  • Checkpoint Therapeutics made up ﹤0.01% of Cetera Advisors's portfolio in Q1 2024, its #2390 holding.
  • 40 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.